ilmn share price forecast

Close price at the end of the last trading day Friday 30th Sep 2022 of the ILMN stock was 19079. Todays Change 1346 656.

Scottish Mortgage Share Forecast Smt Recovery Hangs In The Balance

1 Year change -4368.

. Find real-time ILMN. Analysts covering Illumina currently have a consensus Earnings. ILMN real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions.

In Aug the positive dynamics. ILMN stock analyst estimates including earnings and revenue EPS upgrades and downgrades. According to 25 stock analysts the average 12-month stock price forecast for Illumina stock is 24804 which predicts an increase of 203.

Health Care Pharmaceuticals and Biotechnology. ILMNs one year PEG ratio measuring. Get the latest Illumina Inc.

30 2022 at 600 pm. According to our technical. This is 156 less than the trading day before Thursday 29th Sep 2022.

The average ILLUMINA INC stock forecast 2023 represents a 2258 increase from the last price of 203529998779297. The document has moved here. According to our current ILMN stock forecast the value of Illumina Inc.

Target values for the price of one Illumina share for Aug 2023. The analyst consensus target price for shares in Illumina is 24318. That is 2568 above the last closing price of 19349.

Forecast target price for 10-10-2022. The average ILLUMINA stock price prediction forecasts a potential upside of 3568 from the current ILMN share price of 29665. Shares will rise by 551and reach 21872 per share by September 3 2022.

News and forecasts from CNN Business. On average Wall Street analysts predict that Illumina s share price could reach 25700 by Sep 30 2023. Positive dynamics for Illumina shares will prevail with possible volatility of 1654.

Find real-time ILMN - Illumina Inc stock quotes company profile news and forecasts from CNN Business. The weighted average target price per Illumina share in Aug 2023 is. Illumina has risen higher in 16 of those 22 years over the subsequent 52-week period corresponding to a historical accuracy of 7273.

In the latest trading session Illumina ILMN closed at 19079 marking a -156 move from the previous day. Is Illumina Stock Undervalued. According to the issued ratings of 13 analysts in the last year the consensus rating for Illumina stock is Hold based on the current 1 sell rating 6 hold ratings and 6 buy ratings for.

The average Illumina stock price prediction forecasts a potential upside of 347. Stock Price Forecast. For ILLUMINA INC stock forecast for 2025 12.

The 17 analysts offering 12-month price forecasts. With a market capitalization of 30011267000 ILLUMINA INC has a greater market value than 9324 of US stocks. ILMN price target These targets are based on 21 analysts price predictions made in the past three months for ILMN over the next 12 months.

Eux1txbzs4sem

Illumina Stock Is Investible Despite The Grail Issue Nasdaq Ilmn Seeking Alpha

Ilmn Stock Forecast Price News Illumina

Does The World Have Too Many Hiseq X Tens Enseqlopedia

Lung Cancer Screening Market Size Global Forecast 2022 2027

Illumina Inc Ilmn Stock Price Quote News Stock Analysis

Illumina Inc Ilmn Stock Price Us4523271090 Marketscreener

Illumina Surges After Strong Earnings Price Target Upgrades Thestreet

Genomic Market To Rise At 18 7 Cagr Agilent Technologies Illumina Inc And F Hoffmann La Roche Ltd Together Cover The Maximum Share Finds Fortune Business Insights Markets Insider

Investors Have Very High Expectations For Illumina Nasdaq Ilmn And That Will Put The Share Price At Risk From Further Volatility

Illumina Stock Crashes On Troubling Outlook Sales Miss Stock News Stock Market Analysis Ibd

Mirna Sequencing And Assay Market Share 2022 Global Trend Segme Wicz

Illumina Inc Price Ilmn Forecast With Price Charts

Here S Why You Should Retain Illumina Ilmn Stock For Now Nasdaq

Genetic Testing Market Share Pricing Strategy Industry Latest News Top Company Analysis Research Report Analysis Trends By Forecast 2021 2026 F Hoffmann La Roche Ltd Eurofins Scientific Illumina Inc Qiagen N V Novartis International